Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05362292 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TReating Incontinence for Underlying Mental and Physical Health

Study acronym: TRIUMPH
StatusRecruiting
PhasePhase 4
Started2022-10-04
View on ClinicalTrials.gov ↗

Amendment history

2026-03-04
Study Status v10
Re-verified, no change to tracked fields
2025-12-12
Study Status v9
Primary completion date2026-11-02→2027-05-02
Completion date2027-01-25→2027-08-02
2024-12-03
Study Status v8
Primary completion date2026-09-28→2026-11-02
Completion date2026-12-28→2027-01-25
2024-10-02
Study Status v7
Re-verified, no change to tracked fields
2024-07-31
Study Status, Contacts/Locations v6
Study sitescontacts updated at 1 of 2 sites
Show 5 earlier versions
2023-12-18
Study Status v5
Re-verified, no change to tracked fields
2022-12-07
Study Status v4
Primary completion date2026-11→2026-09-28
Completion date2027-02→2026-12-28
Start date2022-09-19→2022-10-04
2022-09-21
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-08→confirmed 2022-09-19
Study sitesdetails revised at 2 of 2 sites
2022-08-26
Study Status, Arms and Interventions, Outcome Measures v2
Secondary endpoints21 to 45 entries
Change in composite cognitive function over 9 months (36 weeks), using a composite cognitive score onthat verbalincorporates normalized data from all domain-specific cognitive tests. Change in Auditory Verbal Learning Test total learning score assessed fromover baseline6 tomonths (24 weeks) of treatment Change in Auditory Verbal Learning Test total learning score assessed over 9 months (36 weeks). Change Auditory Verbal Learning Test delayed free recall score over 6 months (24 weeks) of treatment. Change Auditory Verbal Learning Test delayed free recall score over 9 m [...] 6 months (24 weeks) of tr [...] [...]
Primary endpoints1 entry, revised
Change in composite cognitive function over 6 months (24 weeks) of treatment, using a composite cognitive score that incorp [...]
2022-07-01
Study Status v1
Start date2022-06→2022-08
2022-05-02
Original filing
The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinary incontinence and either normal or mildly impaired cognitive function at baseline.
Trial Details
NCT Number NCT05362292
Lead Sponsor University of California, San Francisco
Collaborators: National Institute on Aging (NIA)
Conditions Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder, Incontinence, Urge, Incontinence, Urinary, Incontinence
Enrollment 270 participants
Start Date 2022-10-04
Primary Completion 2027-05-02 (estimated)
Study Completion 2027-08-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-06